Corgenix announces that Randox received CE Mark notification for TxBCardio Assay

Corgenix Medical Corporation (OTC BB: CONX.OB) announced in collaboration with Randox Laboratories that Randox has been granted CE Mark notification for its TxBCardio™ Assay. The TxBCardio test measures urinary levels of the thromboxane metabolite 11dhTxB2 to determine aspirin effect in apparently healthy individuals. CE mark designation enables commercial marketing and distribution of the product in Europe.

The TxBCardio automated immunoturbidimetric (IT) assay format enables testing for urinary 11dhTxB2, the thromboxane metabolite measured by the AspirinWorks™ Test (ELISA assay), to be run on clinical chemistry platforms for higher-volume laboratories and in hospitals. The AspirinWorks Test is a simple urine test that measures levels of 11-dehydro thromboxane B2 (11dhTxB2) to determine aspirin effect in apparently healthy individuals. The AspirinWorks Test was FDA-cleared in the U.S. in 2007; the TxBCardio brand was established to better emphasize the importance of the thromboxane biomarker while expanding into new products and technologies. The AspirinWorks ELISA assay continues to be sold worldwide.

"Achieving CE Mark is a significant milestone in our collaborative development efforts with Randox for thromboxane testing," said Douglass Simpson, Corgenix President and CEO. "We're also moving forward with our strategic partner and master distributor, the ELITech Group, to expand global coverage of this new assay and broaden application onto additional platforms."

The TxBCardio assay will be manufactured at Randox Laboratories in the United Kingdom. Both Corgenix Medical and Randox Laboratories will be selling the new test worldwide under the TxBCardio brand name.

The safety and efficacy of the TxBCardio assay has not yet been evaluated by the FDA and therefore is not cleared for clinical diagnostic use in the United States.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Randox Laboratories Ltd.. (2019, June 19). Corgenix announces that Randox received CE Mark notification for TxBCardio Assay. News-Medical. Retrieved on April 16, 2024 from https://www.news-medical.net/news/20140515/Corgenix-announces-that-Randox-received-CE-Mark-notification-for-TxBCardio-Assay.aspx.

  • MLA

    Randox Laboratories Ltd.. "Corgenix announces that Randox received CE Mark notification for TxBCardio Assay". News-Medical. 16 April 2024. <https://www.news-medical.net/news/20140515/Corgenix-announces-that-Randox-received-CE-Mark-notification-for-TxBCardio-Assay.aspx>.

  • Chicago

    Randox Laboratories Ltd.. "Corgenix announces that Randox received CE Mark notification for TxBCardio Assay". News-Medical. https://www.news-medical.net/news/20140515/Corgenix-announces-that-Randox-received-CE-Mark-notification-for-TxBCardio-Assay.aspx. (accessed April 16, 2024).

  • Harvard

    Randox Laboratories Ltd.. 2019. Corgenix announces that Randox received CE Mark notification for TxBCardio Assay. News-Medical, viewed 16 April 2024, https://www.news-medical.net/news/20140515/Corgenix-announces-that-Randox-received-CE-Mark-notification-for-TxBCardio-Assay.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New Liquid ready-to-use Tumour Marker Control available now from Randox